Early phase studies with real-world execution
Phase I-unit capabilities
Facility and staffing
✓ 11 inpatient beds for confinement and intensive schedules
✓ Around-the-clock coverage by licensed medical staff
✓ Participant areas set for multi-day stays, with private bathrooms and showers
Pharmacy and lab on site
✓ On-site pharmacy with secure storage and biosafety cabinet
✓ PBMC laboratory for controlled sample handling and storage
✓ IATA certified sample handling
✓ CLIA-supported safety laboratory
Study scope
✓ BA and BE, PK and PD, ADME and ethno bridging
✓ First in human, dose escalation, and device-focused protocols
✓ Fast access to diagnostic and imaging centers
✓ Ability to run chronic oncology and chronic condition studies
Phase I deliver in numbers
These results reflect mature recruitment pathways, engaged investigators, and a setup that keeps participants in the study through confinement and follow-up.
Participant experience and safety
Retention-focused environment for confined and high-touch studies.
- Private patient rooms with room recliners and beds
- Dedicated patient bathrooms with showers
- Assessment room for procedures and safety checks
- Conference room for study team huddles and reviews
- Patient retention amenities including Wi Fi, meal delivery, and recreational spaces
Compelling reasons to partner with us for success
Stepping beyond Phase I
Early work in this unit can transition into Phase II to III across our outpatient and community sites, maintaining continuity in team and processes.